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Introduction
It has been revealed that the tumor suppressor gene p53 plays a pivotal role in regulating cell cycle progression and helps repair and/or eliminate mutated genes by inducing G1 arrest in response to DNA damage. 1 Overexpression of p53 induces apoptosis both in normal cells and in certain cancer cells, leading to a suppression of tumor growth. [2] [3] [4] [5] It has also been reported that p53 may increase sensitivity to anticancer drugs. 6, 7 In human lung cancer, p53 is the gene that is most frequently mutated. 8, 9 Taken together, all this suggests that gene transfer leading to expression of the wild-type p53 may prove to be an effective strategy for the treatment of lung cancer.
For future gene therapy with p53, the vectors should be capable of achieving gene transduction at a high level of efficiency. Accumulating evidence suggests that a recombinant adenovirus may be a promising vector for in vivo gene transfer into various kinds of cancer cells, including those found in lung cancer. [10] [11] [12] However, before considering in vivo studies, we need systematically to investigate whether adenovirus-mediated gene transfer actually is effective in most lung cancer cells in vitro. If the expression level of the transferred gene should prove to vary among cell lines, we would need to examine whether the variance simply reflects the infection efficiency or whether it is due to variations in other intra-cellular mechanisms. Furthermore, if the infection efficiency is the critical determinant of the efficiency of gene induction, a practical way of estimating the infection efficiency would be needed to help us make a decision about the best form of adenovirus-mediated gene therapy for each type of cancer cell.
In this study we used 15 cell lines derived from human lung cancer to quantify the efficiency of adenovirusmediated gene transfer. We then investigated the effects of p53 gene transfer in terms of growth suppression and apoptosis. We found that susceptibility to adenovirus varies considerably among cancer cells (even among cells from the same organ), and that the amount of integrin ␣ v ␤5 is closely correlated with the level of gene expression following adenovirus-mediated gene transfer. We observed a growth-inhibitory effect of p53 in all cells tested, including a cell line that has the wild-type p53 gene, provided a sufficient amount of p53 protein was expressed. Our results confirm the importance of determining the susceptibility of targeted cancer cells to adenoviral vectors both before considering adenovirusmediated gene transfer and for evaluating its therapeutic effects. Further, they suggest that quantification of integrin ␣ v ␤5 may be a good way of predicting the susceptibility of particular cancer cells to adenoviral vectors. this purpose, we used an adenovirus expressing bacterial ␤-galactosidase (AdCALacZ). Cell lines were infected with AdCALacZ at MOI 50, and the ␤-galactosidase (␤-gal) activity was measured. The ␤-gal activity showed considerable differences among the cell lines ( Figure 1 ). The activity was highest in H157 cells, and was 11 times higher than that seen in LC-1 cells (Figure 1 ). We then measured the expression levels of lacZ attained with AdCALacZ at various MOI in the cases of H460 and H157 cells (Figure 2) . At all MOI, the ␤-gal activity in H460 cells was low by comparison with that in H157 cells, but a graded increase was observed in H460 cells as the MOI was increased. In fact, the ␤-gal activity in H460 cells at MOI 400 was comparable to that in H157 cells at MOI 50. The growth of H460 cells infected with AdCALacZ at MOI 400 was not significantly affected.
Results

Efficiency
Correlation between expression level of integrin subunits and the cell's susceptibility to adenoviral infection Since a graded increase in the expression level of the transferred gene was observed even in H460 cells, we assumed that a low level of expression might reflect a low efficiency of infection (ie a low 'susceptibility') rather than a difference in other intracellular mechanisms. We decided to quantify the level of the integrin subunits, ␣ v , ␤3 and ␤5, in the cancer cells under study, since integrin is thought to be important for the adherence and internalization of an adenovirus into cells. 13, 14 As shown in Figure 3 , immunoblotting analysis showed that a summation of the amounts of integrins ␣ v and ␤5 correlated with ␤-gal activity following infection with AdCALacZ (see Figure 1 ). In contrast, the level of integrin ␤3 did not show any correlation with ␤-gal activity (data not shown). These results support the notion that integrin ␣ v ␤5 may be an adherence and internalization receptor for adenoviruses, and suggest that a lower gene expression following adenovirus-mediated gene transfer may, at least in part, be a consequence of a lower efficiency of infection.
Growth inhibition by AdCAp53 depends simply on expression level of p53, regardless of genetic status of endogenous p53 gene Next, we investigated the effect of an adenovirusmediated overexpression of wild-type p53 on cell growth.
For this, we used four lung cancer cell lines that differ in terms of the status of their endogenous p53 gene; H157 and H322 have a mutation on their p53 gene; H1299 has a deleted p53 gene; and H460 has an intact p53 gene. 15 Cells were infected with either AdCAp53 or AdCALacZ at various MOI, and cell growth was monitored daily using an MTT assay. In H1299 and H157 cells that are adenovirus-sensitive, cell numbers began to decrease 48 h after infection with AdCAp53 at MOI 50, and virtually all cells had died by the fourth day after infection (Figure 4a and b). The condensed nucleus that is a characteristic of apoptosis was seen in these cells, when they were stained with bisbenzimide 33258 (Figure 5a and b).
Figure 4 Growth curves for human lung cancer cell lines, NCI-H157, H1299, H460 and H322, after infection with AdCAp53. Cells in 96-well plates were infected with either AdCAp53 or AdCALacZ at a MOI of 50. Cell proliferation was monitored by an MTT assay. Data are shown as means (n = 6). Closed circles, triangles and squares showed the growth curve of each cell line when uninfected, infected by AdCALacZ at MOI 50 and infected by AdCAp53 at MOI 50, respectively.
Cells infected with AdCALacZ at MOI 50 showed little change in growth rate compared with their uninfected counterparts, indicating that the observed inhibition of growth was not due to adenoviral infection per se.
In contrast, either nominal or only partial inhibition of cell growth was observed in H460 and H322 cells that are adenovirus-resistant, after infection with AdCAp53 at MOI 50 (Figure 4c and d) . We assumed that, in these cells, the amount of p53 protein was insufficient to induce growth inhibition or apoptosis when they were infected with AdCAp53 at MOI 50, and that cell arrest might be achieved if they were infected at a higher MOI. In fact, when H460 cells were infected with AdCAp53 at MOI 400, at which MOI the level of gene expression was comparable to that seen following infection of H157 cells with AdCALacZ at MOI 50 (see Figure 2) , an increased amount of p53 protein of normal molecular weight was expressed ( Figure 6 ) and cell growth was significantly suppressed (Figure 7 ). This observation suggests that growth arrest might be achieved even in cancer cells in which the p53 gene is intact, provided the expression of a sufficient amount of p53 protein can be evoked.
Inspection of Figures 6 and 7 reveals that the static level of p53 protein in H460 infected at MOI 400 was about five times higher than that seen at MOI 20. However, even this higher level was still lower than the level seen in H157 cells infected at MOI 20 and lower than that expected from the level of ␤-gal activity detected after infection with AdCALacZ (Figure 2 ). Until the fourth day after infection at MOI 400, the H460 cells remained quiescent, but they grew gradually thereafter (Figure 7 ).
Discussion
As a way of providing some of the basic information needed before adenovirus-mediated gene transfer into lung cancer is attempted in vivo, we characterized the efficiency of gene transduction by an adenoviral vector in a variety of cell lines derived from human lung cancers. We found that the efficiency of gene transduction achieved by adenoviral infection varied considerably among these cell lines. The susceptibility to a given adenoviral vector (rather than variations in other intracellular mechanisms involved in transcription and/or translation) seems to determine the level of gene transduction in the cancer cell lines tested. The evidence for this is that the expression level of integrin (which is thought to be an adherence receptor for adenoviruses) was proportional to the level of gene expression (Figures 1 and 3) . In any clinical application of such an infection technique, knowledge of the susceptibility of target cells to the appropriate adenoviral vectors would be an important part of patient selection. It would also be critical for the proper evaluation of any therapeutic effect that followed adenovirus-mediated gene transfer.
It has recently been reported that the vitronectin-binding integrins, ␣ v ␤3 and ␣ v ␤5, promote an internalization of type 2 adenovirus into cells through an interaction with the virus' pentone bases. 13 Since the primary structure of the pentone base is conserved among adenovirus serotypes, 13 integrins ␣ v ␤3 and ␣ v ␤5 should also function as adherence receptors for the type 5 adenovirus, from 
Figure 7 Growth suppression in H460 cells infected with AdCAp53 at MOI 400. H460 cells were infected with either AdCAp53 (squares) or AdCALacZ (triangles) at MOI 400, or left uninfected (circles), then the growth was monitored using an MTT assay. Each point represents the mean of six determinations.
which the adenoviral vectors used in this study were derived. It has been shown that the integrin subunits ␤1 and ␤4 are expressed fairly ubiquitously in lung cancer cells as common subunits, whereas ␤3 and ␤5 subunits are not detected in every lung cancer cell type. 16, 17 Our semiquantitative measurement of integrins ␣ v , ␤5 (Figure 3) , and ␤3 (data not shown) showed that the expression level of these integrin subunits varied considerably among the cell lines examined. However, the total amount of ␣ v plus ␤5 seemed to correlate with the cell's susceptibility to adenovirus (Figures 1 and 3) . The result suggests that quantification of a cell's integrin ␣ v ␤5 may be a good way of predicting its susceptibility to an adenoviral vector. The expression pattern of integrin subunits differs between small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). 18 Cell lines derived from NSCLC express all beta subunits, whereas SCLC cells usually express only the ␤1 subunit. In fact, N417 cells (the only cell line derived from SCLC among the 15 cell lines tested here) expressed ␣ v ␤5 only at a minimal level (Figure 3) , and showed a low susceptibility to AdCALacZ (Figure 1 ). These findings may suggest that adenovirus-mediated gene transfer will be less effective in SCLC than in NSCLC, though more cell lines will need to be studied to test this idea. Ascadi et al 14 observed a positive relationship between the expression level of integrin ␤3/␤5 and the efficiency of adenovirus-mediated gene transduction during differentiation of a skeletal muscle cell line. However, only two stages of one cell line were examined in their study, so it is difficult to draw a generalized conclusion. In the present study, we have examined 15 lung cancer cell lines and reached a similar conclusion. Our results significantly reinforce and extend their idea.
The association between the amount of ␣ v /␤5 integrin and the ␤-gal activity in lung cancer cells tested was not totally justified, although a general tendency can be recognized. The amount of integrin was assessed by Western blotting, which is neither an accurate nor consistent method for determining the amount of protein. Furthermore, the signal was then quantified by a densitometer, in which a further error could have been generated. We repeated the same experiment three times and observed a similar correlation each time. However, some variation in the amount of integrin ␣ v /␤5 was observed between experiments. Other types of integrin might be involved in the adenoviral infection, thus measurement of such integrins (and summation with the amount of ␣ v /␤5) might show a tighter association. Recently, a specific receptor for adenovirus, which is in fact a common receptor for coxsackie B virus, has been cloned. 19 Bergelson and co-workers report that a viral fiber attaches to this receptor, and that transfection of this receptor to cells led to a 100-fold increase in their susceptibility to the adenovirus. Thus, It could be that cells expressing the more specific receptor for the adenovirus have a greater susceptibility to the virus, even though the level of integrin ␣ v /␤5, which may attach to a penton base of the virus, is not very high. Further studies will be required to test this hypothesis.
We examined the inhibitory effects of adenovirusmediated overexpression of the wild-type p53 gene on the growth of four cancer cell lines among which the status of the endogenous p53 gene differs. In H157 and H1299 cells, which are sensitive to adenovirus and have a mutated p53 gene, complete suppression of cell growth, as well as apoptosis, was induced by infection with AdCAp53 at low MOI. In contrast, only a nominal inhibition was observed in H460 and H322 cells (both of which have a low susceptibility to adenovirus). Importantly, growth inhibition was also induced in H460 cells when a certain level of p53 protein was expressed following infection with AdCAp53 at higher MOI (Figures 6 and 7) . This observation suggests that the apparent ineffectiveness of AdCAp53 (at MOI 50) in H460 cells is probably, at least in part, due to an insufficient level of p53 protein because of the low susceptibility of this type of cell to adenoviral vectors. This finding confirms the importance of determining the susceptibility of target cells to a given vector before attempting to evaluate the efficacy of gene transfer treatment. The data is consistent with the assumption that overexpression of p53 could be effective in inhibiting proliferation of cancer cells that have the wild-type p53 gene. This notion, however, needs to be examined carefully using many other cancer cell lines harboring the wildtype p53 gene. The fact that H460 cells infected with AdCAp53, even at a large MOI, began to proliferate 4 days after infection (Figure 7 ) may suggest that H460 cells have the capability to abort the function of p53 or to degrade p53 protein quickly. The latter possibility would be consistent with the finding that the static level of p53 protein in H460 cells was less than that expected from the level of ␤-gal activity following infection with AdCALacZ ( Figure 6 ). Interestingly, in a study in which a similar adenovirus expressing the wild-type p53 was used to infect cancer cells (including four lines with the wild-type p53 gene), it has been found that cancer cells harboring the wild-type p53 are less sensitive to exogenous p53 protein than cells that have mutations or a deletion at their p53 gene. 20 This would seem to be consistent with our results.
In summary, our data indicate the importance of determining the susceptibility of targeted cells to adenoviral vectors both to inform decision-making about the use of adenovirus-mediated gene transfer in vivo and for evaluating its therapeutic effects. They also suggest that quantitative measurement of the level of integrin ␣ v ␤5 in human lung cancer cells may be a useful predictor of the likely efficiency and effectiveness of gene transfer by means of an adenoviral vector.
Materials and methods
Cell culture
The human lung cancer cell lines, NCI-H157, NCI-H460, NCI-H1299, NCI-H322, NCI-H522, NCI-H358 (kindly provided by Dr AF Gazder, University of Texas Southwestern Medical Center, Dallas, TX, USA), EBC, LC-1, PC9, A549, LK2, N417 (obtained from Health Science Research Resources Bank, Tokyo, Japan), QG56, QG90, QG95 (provided by National Kyushu Cancer Center, Fukuoka, Japan) were maintained with RPMI 1640 medium supplemented with 5% fetal bovine serum (GIBCO-BRL, Grand Island, NY, USA) and penicillin/streptomycin in a humidified incubator with 5% CO 2 at 37°C.
Preparation of adenoviral vectors Replication-defective E1
− and E3 − adenoviral vectors were prepared as described previously. [21] [22] [23] [24] [25] Briefly, a cDNA coding for human wild-type p53 (kindly provided by Dr Vogelstein, Johns Hopkins Oncology Center, Program in Human Genetics, Baltimore, MD, USA) was placed into a cassette cosmid vector, pAdexCA1w (provided by Dr Saito, University of Tokyo), under a CA promoter comprising a cytomegalovirus enhancer and chicken ␤-actin promoter (pAdex1w/p53). A recombinant adenovirus was constructed by in vitro homologous recombination in 293 cells using pAdex1w/p53 and the adenovirus DNA-terminal protein complex. 24 The desired recombinant adenovirus, designated AdCAp53, was purified by ultracentrifugation through a CsCl 2 gradient followed by extensive dialysis. Contamination of wild-type adenovirus was excluded by the polymerase chain reaction designed for E1 amplification. The titer of the virus stock was assessed by a plaque-formation assay using 293 cells and expressed as plaque formation unit (p.f.u.). We also prepared control adenoviruses, AdCALacZ expressing bacterial ␤-galactosidase, and Adex1w which did not contain any exogenous gene to be expressed. [21] [22] [23] 25 In vitro gene transfer into lung cancer cells Cells rinsed with serum-free medium twice were added to recombinant adenovirus, which was diluted to a desired titer with serum-free medium. After incubation for 2 h at room temperature under gentle agitation, the medium containing an adenovirus was removed, washed and incubated in fresh growth medium until used for assays.
Quantification of ␤-galactosidase activity Cells (2 × 10 5 ) were infected with AdCALacZ at various MOI. Three days later, cells were harvested in a lysis buffer. Expression of lacZ was quantified by measuring ␤-galactosidase (␤-gal) activity by a colorimetric assay using chlorophenol red-3-d-galactopyranoside (Boehringer Mannheim Biochemica, Frankfurt, Germany) 26 as described previously. [21] [22] [23] The activity of ␤-gal was normalized with respect to the protein content as determined by a dye-binding assay. 27 
MTT assay
The cell proliferation was monitored spectrophotometrically using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma Chemical, St Louis, MO, USA) as described previously. 28, 29 Briefly, cells (1.5 × 10
3 ) in 96-well plates were infected with an adenovirus, then 0.1 mg MTT was added and incubated for 4 h at 37°C. The plate was then centrifuged at 800 g for 10 min and the medium removed. MTT formazan crystals were then solubilized by adding 200 l dimethylsulfoxide and absorbance at 540 nm was measured using an automated microplate reader (Easy Reader EAR 340; SLT Labinstruments, Austria).
Immunoblotting H157 and H460 cells (5 × 10 5 ) were infected with AdCAp53 at MOI 20. Two days later, cells were lysed in a lysis buffer (50 mm Tris (pH 7.5), 250 mm NaCl, 0.1% NP-40, 5 mm EDTA and 1 mm phenylmethylsulfonylfluoride), separated by 10% SDS-PAGE and transferred to a nitrocellulose membrane. The membrane was probed with an anti-human p53 antibody (DO-1; Oncogene Science, Cambridge, MA, USA) followed by a sheep anti-mouse IgG conjugated with horseradish peroxidase. p53 Protein was visualized by chemiluminescence (ECL Western Blotting Analysis System; Amersham, Little Chalfont, UK) on a film (Fuji XAR; Fujifilm, Tokyo, Japan). The relative intensities were measured by densitometry. Integrins ␣ v , ␤3 and ␤5 were also quantified by immunoblotting with the corresponding anti-integrin serum (Chemicon International, Temecula, CA, USA).
Detection of apoptosis H157 cells were infected with AdCAp53 at MOI 20. Two days later, cells were harvested and fixed in 4% paraformaldehyde for 2 h at 4°C. Fixed cells were stained with 0.2 mm bisbenzimide 33258 (Wako Pure Chemical, Osaka, Japan) for 15 min at RT as previously described 30 and observed under a fluorescence microscope (BHS-RFC; Olympus, Tokyo, Japan).
